Tempus AI's Valuation: Is its Price Reflective of its AI Healthcare Story?

Tempus AI (TEM) has returned 11.1% year-to-date and 117.6% over the last year. Recent coverage has focused on the company's positioning in AI-driven healthcare data. Tempus AI has a valuation score of 3/6, meaning it screens as undervalued on half of the checks used. The company's discounted cash flow analysis suggests an intrinsic value of $183.10 per share, implying a 62.2% discount to the current share price, screening as materially undervalued.